WE
CATX icon

Wealth Effects’s Perspective Therapeutics CATX Stock Holding History

Wealth Effects’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$119K Buy
35,000
+2,000
+6% +$7.56K 0.03% 247
2026
Q1 		$138K Buy
33,000
+8,000
+32% +$33.8K 0.05% 224
2025
Q4 		$68.8K Sell
25,000
-1,000
-4% -$2.85K 0.02% 214
2025
Q3 		$89.2K Buy
26,000
+2,000
+8% +$7.29K 0.03% 212
2025
Q2 		$82.6K Sell
24,000
-15,000
-38% -$39.6K 0.03% 202
2025
Q1 		$83.1K Buy
39,000
+1,000
+3% +$3K 0.03% 194
2024
Q4 		$121K Buy
38,000
+24,750
+187% +$202K 0.04% 205
2024
Q3 		$177K Sell
13,250
-4,100
-24% -$54.5K 0.06% 202
2024
Q2 		$173K Buy
17,350
+5,600
+48% +$81K 0.06% 192
2024
Q1 		$140K Sell
11,750
-250
-2% -$2.13K 0.05% 207
2023
Q4 		$48.2K Buy
12,000
+1,000
+9% +$2.81K 0.02% 222
2023
Q3 		$30.1K Hold
11,000
– – 0.01% 191
2023
Q2 		$73.5K Hold
11,000
– – 0.03% 195
2023
Q1 		$70.2K Hold
11,000
– – 0.04% 192
2022
Q4 		$27.2K Hold
11,000
– – 0.02% 187
2022
Q3 		$25K Buy
11,000
+10,000
+1,000% +$34.2K 0.02% 182
2022
Q2 		$3K Hold
1,000
– – ﹤0.01% 189
2022
Q1 		$4K Hold
1,000
– – ﹤0.01% 204
2021
Q4 		$4K Buy
+1,000
New +$5.33K ﹤0.01% 215

Other funds holding CATX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

Wealth Effects's CATX Position: Q2 2026 in Review

Wealth Effects increased its Perspective Therapeutics (CATX) stake by 6.1% in Q2 2026, buying an estimated $7.56K and bringing the position to 35,000 shares worth $119K. The position accounts for 0.03% of the portfolio, ranked #247.

Wealth Effects first reported a position in CATX in Q4 2021 and has held it in 19 quarters since. The position peaked at $177K in Q3 2024. 132 funds tracked by Wall St. Rank hold CATX as of Q2 2026.

  • Wealth Effects held 35,000 shares of Perspective Therapeutics worth $119K as of Q2 2026.
  • Wealth Effects bought 2,000 Perspective Therapeutics shares in Q2 2026, an estimated $7.56K.
  • Perspective Therapeutics made up 0.03% of Wealth Effects's portfolio in Q2 2026, its #247 holding.
  • Wealth Effects first reported a position in Perspective Therapeutics in Q4 2021 and has held it in 19 quarters since.
  • Wealth Effects's Perspective Therapeutics position peaked at $177K in Q3 2024.
  • 132 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q2 2026.

Based on Wealth Effects's 13F filing for Q2 2026, filed 6 Aug 2026.